Diabetes Alone should not be a Reason for Withholding Adjuvant Chemotherapy for Stage III Colon Cancer

Diabetes Alone should not be a Reason for Withholding Adjuvant Chemotherapy for Stage III Colon Cancer

Background With increasing prevalence of diabetes mellitus and colon cancer, the number of patients suffering from both diseases is growing, and physicians are being faced with complicated treatment decisions. Objective To investigate the association between diabetes and treatment/course of stage II...

Full description

Bibliographic Details
Main Authors: Maren A. van Waalwijk, Saskia A. M. van de Schans, Harm R. Haak, Martine Extermann, Wouter M. W. Dercksen, Maryska L. G. Janssen-Heijnen
Format: Article
Language:English
Published: SAGE Publishing 2011-01-01
Series:Journal of Comorbidity
Online Access:https://doi.org/10.15256/joc.2011.1.7

Internet

https://doi.org/10.15256/joc.2011.1.7

Similar Items